Advent Life Sciences sells KaNDy to Bayer AG

Advent Life Sciences has sold KaNDy Therapeutics Ltd to Bayer AG.

12 August 2020•3 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Healthcare M&A Deals Briefs